Pathway analysis of the genes with altered splicing by indisulam and RBM39 knockdown revealed that loss of RBM39 affected pathways involved in G2-M phase cell cycle, gene transcription, DNA repair, chromatin-modifying enzymes, metabolic pathways, and cancer genes (fig. Here, RBM39 is linked to cancer.